Empowering Plans: P187 – Decoding ACA FAQ #66: Essential Health Benefits Unpacked
April 11, 2024
Listen in as Kelly Dempsey and Brian O'Hara hit it out of the park in this Empowering Plans episode about Essential Health Benefits (EHBs)! The regulating bodies are at it again and issued ...
Full Podcast: Empowering Plans: P187 – Decoding ACA FAQ #66: Essential Health Benefits Unpacked
Understanding IDR | Key Insights on the No Surprises Act
April 8, 2024
By: Jon Jablon, Esq. It seems like every day that The Phia Group's consulting team is presented with an IDR-related issue brought up by either a provider in an appeal or simply a TPA trying ...
Full Blog: Understanding IDR | Key Insights on the No Surprises Act
The Phia Group Is Named Winner of the 2024 Top Workplaces USA Award
April 3, 2024
Canton, MA For Immediate Release The Phia Group, a leading provider of health care cost containment solutions, proudly announced today that it has been honored with the 2024 Top Workplaces ...
Full Press Release: The Phia Group Is Named Winner of the 2024 Top Workplaces USA Award
Medicaid Estate Recovery | Understanding the Implications
April 3, 2024
By: David Ostrowsky It is the most nightmarish version of a wolf at the door. Imagine that you have recently lost a loved one, are still in the midst of grieving, feeling sleep deprived, ...
Full Blog: Medicaid Estate Recovery | Understanding the Implications
Lenmeldy | Exploring the Price of the New Gene Therapy
April 1, 2024
By: Kendall Jackson, Esq. The U.S. Food and Drug Administration (FDA) stoked the fire that is the ever-present discussion surrounding gene therapy when it approved Lenmeldy on March 18, ...
Full Blog: Lenmeldy | Exploring the Price of the New Gene Therapy
The Phia Group Announces the Addition of the Renowned John Blaney as Their Chief Innovation Officer
March 28, 2024
Canton, MA For Immediate Release Rarely can an organization with decades of industry leading ascendency truly claim to make a change that will both revolutionize its fundamental essence to ...
Full Press Release: The Phia Group Announces the Addition of the Renowned John Blaney as Their Chief Innovation Officer
Empowering Plans: P186 – Xenotransplantation: A Potential Game Changer for Self-Funded Plans
March 28, 2024
Ham it up with attorneys Nick Bonds and Jen McCormick from the Phia Group as they dive into the groundbreaking world's first successful genetically engineered pig kidney transplant at MGH ...
Full Podcast: Empowering Plans: P186 – Xenotransplantation: A Potential Game Changer for Self-Funded Plans
Wegovy: Not Just a Weight Loss Drug
March 20, 2024
By: David Ostrowsky As if there weren’t enough buzz surrounding Wegovy. Earlier this month, the wildly popular weight loss medication was approved in the US to help prevent ...
Full Blog: Wegovy: Not Just a Weight Loss Drug
Empowering Plans: P185 – Weighing the Options
March 14, 2024
Over the last twelve months we have seen major interest in GLP-1s (Semaglutide- Ozempic / Wegovy and Tirzepatide – Mounjaro / Zepbound). Although GLP-1s have been around for years as a ...
Full Podcast: Empowering Plans: P185 – Weighing the Options
Significant Effects of a Recent Healthcare Cyberattack
March 11, 2024
By: Andrew Silverio, Esq. It’s not often we see a healthcare/health benefit story so big that it crosses into the mainstream. The recent cyberattack in the healthcare industry is just that ...
Full Blog: Significant Effects of a Recent Healthcare Cyberattack